Dingerdissen J J, Sitrin R D, DePhillips P A, Giovenella A J, Grappel S F, Mehta R J, Oh Y K, Pan C H, Roberts G D, Shearer M C
J Antibiot (Tokyo). 1987 Feb;40(2):165-72. doi: 10.7164/antibiotics.40.165.
An unidentified Nocardia sp. (SK&F-AAJ-193) was isolated and found to produce actinoidin A and a novel analog which we have named actinoidin A2. This new glycopeptide antibiotic differs from actinoidin A by the presence of rhamnose instead of acosamine. This analog was isolated using Dianion HP-20 resin followed by a specific glycopeptide affinity column (Affigel-10-D-Ala-D-Ala). The purification was accomplished using preparative ion-pairing chromatography. Actinoidin A2 is active against Staphylococcus aureus and coagulase-negative Staphylococci although it is less potent than actinoidin A.
一株未鉴定的诺卡氏菌(SK&F-AAJ-193)被分离出来,发现它能产生放线菌素A和一种新的类似物,我们将其命名为放线菌素A2。这种新的糖肽抗生素与放线菌素A的不同之处在于,它含有鼠李糖而非阿可糖胺。该类似物通过使用Dianion HP-20树脂,然后通过特定的糖肽亲和柱(Affigel-10-D-Ala-D-Ala)进行分离。纯化过程采用制备型离子对色谱法完成。放线菌素A2对金黄色葡萄球菌和凝固酶阴性葡萄球菌有活性,尽管其效力低于放线菌素A。